BIO-Europe returns to Cologne, Germany, November 9–11, 2026, as Europe’s largest and most comprehensive life science event. Now in its 32nd year, BIO-Europe will bring together 8,000+ senior decision-makers from 3,400+ companies across 60+ countries for the partnering you rely on, plus an expanded strategic programme you won’t find anywhere else.

This year’s event delivers the proven one-to-one partnering that has made BIO-Europe the epicenter of biotech dealmaking, now enhanced with additional content tracks expanding beyond partnering and covering regulatory strategy, clinical development and biomanufacturing. Whether you’re seeking licensing opportunities, investment or cross-functional strategic insight, BIO-Europe 2026 offers a larger, more relevant experience with new audiences to connect with and critical industry topics to explore.

From emerging innovators to global pharma leaders, BIO-Europe remains the must-attend event for anyone advancing partnerships, assets, and strategies across the international life sciences landscape.

For more information click here.